If you require further searching capabilities for announcements please email: data@nzx.com

L&Q Notice – Rua Bioscience Limited

22/10/2020, 08:38 NZDT, OFFER

LISTING AND QUOTATION NOTICE: NZX MAIN BOARD RUA BIOSCIENCE LIMITED ("RUA") ORDINARY SHARES Company: Rua Bioscience Limited Issuer Code: RUA ISIN: NZRUAE0004S1 Short Name: Rua Bioscience Registered Office: 1 Commerce Place, Awapuni Gisborne 4071 Website: www.ruabio.com Telephone Number: +64 (6) 390 6938 Financial Year End: 30 June Nature of Business: Rua is a New Zealand pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in Te Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company to obtain a licence to cultivate cannabis for research purposes and the Company's co-founder was actively involved in both the establishment of the key industry association and the development of the regulatory framework that is now in place to govern the sector. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain. Rua operates only in the medicinal part of the cannabis sector and has no plans to enter the recreational cannabis market in New Zealand or in any other country. Directors: Trevor Burt, (Chairman), Anna Stove, Martin Smith, Brett Gamble, and Panapa Ehau Details of Issue: The Offer consists of 40 million Shares Quoted Securities at Completion of Offer: 140,012,225 Minimum Application Amount: The minimum Application amount for eligible residents in the Gisborne constituency or shareholder of Waiapu Investment Limited is 200 Shares. 2,000 shares and thereafter in multiples of 100 shares under the Priority Offer Offer Price: $0.5 per share Tick Size: $0.01 Lead Manager: Northington Partners Co-Manager: Forsyth Barr Limited Auditors: Pricewaterhouse Coopers Solicitors: Lowndes Jordan Registrar: Computershare Investor Services Limited Settlement Status: NZCDC Settlement System Product Disclosure Statement Dated: 25 September 2020 Priority Offer and Broker Firm Opens Monday, 5 October 2020 Priority Offer Closes Tuesday, 13 October 2020 Broker Firm Offer close Friday, 16 October 2020 Allotment Date: Wednesday, 21 October 2020 Earliest Mailing of Holder Notices: Friday, 23 October 2020 Expected Commencement of Trading on the NZX Main Board: Thursday, 22 October 2020 Mark Peterson Chief Executive Officer NZX Limited 25 September 2020 End CA:00361859 For:RUA Type:OFFER Time:2020-10-22 08:38:28